The SEC has paused Nasdaq's approval for bitcoin options amid CME's challenge on regulatory jurisdiction, leading to uncertainty over QBTC.
The U.S. Securities and Exchange Commission (SEC) has opted to halt the approval process for Nasdaq's bitcoin options, known as QBTC, in response to a challenge from CME Group. This decision was announced in an order released on July 31.
In May, the SEC had conditionally approved the listing of these options on Nasdaq PHLX, but they still require clearance from the Commodity Futures Trading Commission (CFTC) before a launch can occur.
CME Group contested the SEC's initial approval, claiming that since bitcoin qualifies as a commodity, the associated options should be regulated under the CFTC's jurisdiction. If accepted, this argument could restrict the SEC's power to authorize QBTC, possibly requiring Nasdaq to either register as a CFTC-regulated trading venue or modify its contracts to conform to securities regulations.
Currently, CME operates regulated markets for bitcoin derivatives, while Nasdaq's proposed product would potentially compete without adhering to the same regulatory framework governing CME's offerings. CME's challenge raises concerns that approving Nasdaq's options might allow securities exchanges to list derivatives for other commodities.
The SEC's order has kept the approval suspended since CME filed its challenge on June 11, and it invites feedback from stakeholders until August 24. The initial approval from May was based on the expectation that the CFTC would grant the necessary exemptions for Nasdaq to proceed. However, CME contended that such exemptions should not transfer regulatory authority between agencies.
As it stands, the future of QBTC remains uncertain while the SEC conducts a comprehensive review of the situation.
